{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-254959","form_type":"8-K","ticker":"RCEL","cik":"0001762303","company_name":"AVITA Medical, Inc.","filed_at":"2022-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.954432+00:00","generated_at":"2026-06-23T06:26:48.311760+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Avita Medical terminates CEO Michael Perry, appoints James Corbett as President and CEO","bullets":["Dr. Michael Perry terminated as President and CEO effective Sept 28, 2022; he remains a director.","James Corbett appointed President and CEO; previously a non-executive director since July 2021.","Corbett receives $600,000 annual base salary, $1M stock option grant (4-year vest), target bonus 60%.","Corbett has ~40 years med device experience, CEO of Microtherapeutics, ev3, Alphatec Spine.","Initial employment term of 3 years with automatic one-year renewals; Corbett also joins Board as executive."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-254959","json":"https://secwatch.observer/filing/0001193125-22-254959.json","markdown":"https://secwatch.observer/filing/0001193125-22-254959.md","text":"https://secwatch.observer/filing/0001193125-22-254959.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/d406535d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:26:48.311760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1da52afb0f","claim":"James Corbett was appointed as President and CEO at AVITA Medical, Inc..","evidence_excerpt":"Effective September 28, 2022, the Board of Directors of the Company appointed James Corbett as the Company’s President and CEO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and CEO"}],"fact_type":"executive_change"},{"claim_id":"863b1cf54e","claim":"Michael Perry was terminated as President and CEO at AVITA Medical, Inc..","evidence_excerpt":"Effective September 28, 2022, the Board of Directors of Avita Medical, Inc. (the “Company”) terminated the employment of Dr. Michael Perry, the Company’s President and CEO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1762303/000119312522254959/0001193125-22-254959-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"President and CEO"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}